Venture Valuation and Biotechgate to Participate in the 2024 BIO International Convention in San Diego

ZURICH, Switzerland, May 2024 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation in the highly anticipated 2024 BIO International Convention taking place June 3-6, 2024, at the San Diego Convention Center, in San Diego, California, USA.

The annual BIO International Convention, hosted by Biotechnology Innovation Organization (BIO), is the world’s largest industry gathering and brings together thousands of global biotechnology and biopharmaceutical leaders. The four-day event includes networking, programming and partnering opportunities.

The Company welcomes attendees to visit booth number 2111 in the Swiss Biotech Pavilion to learn more about its independent valuation services, life sciences database, and quarterly partnering events. Its team of experts will be available for discussions and to provide insights into solutions for the ever-evolving biotech landscape. Registered attendees can also schedule a one-on-one meetings with the Company’s delegates using the conference portal.

The Company Chief Executive Officer, Dr. Patrik Frei, and Senior Consultant, Dr. Gergely Iványi, will be presenting a course on the topic of “Product and Company Valuation” on June 2, 2024, also at the San Diego Convention Center. The course will teach how to produce a valuation to be used in investment rounds, mergers and acquisitions, licensing deals, or strategic decisions in the life sciences industry.

About Venture Valuation:

Venture Valuation was founded in 1999 based on profound research work by the founder and CEO, Dr. Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). The company has remained true to its mission: the independent assessment and valuation of companies, products and assets.

The focus lies on technology companies in fast-growing markets and industries including pharmaceuticals, biotechnology, medical technology, nanotechnology, renewable energies and information technology / computer science / software. Clients include both, investors as well as finance-seeking companies themselves, and are domiciled on almost all continents.  Over the course of more than two decades, key strengths and expertise have been built in the life sciences industry.

About Biotechgate:

Biotechgate is a leading business development and licensing database for the entire life science industry, offering a wealth of information on over 60,000 life science company profiles. Thanks to its unique data-sourcing process, the profiles include company descriptions, contact information, product pipeline information, financing rounds, and management details, making it an invaluable resource for big pharma, start-ups, investors, and other industry professionals. Biotechgate also features 35,000 licensing deals and a clinical trials database containing over 900,000 records from registries around the world.